Lee Hartner
Impact in
- Toxicology top 10%
- Bioactive Compounds and Antitumor Agents
-
- Sarcoma Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Sarcoma Diagnosis and Treatment 13
- Renal cell carcinoma treatment 2
- Oncology 16
- Vascular Tumors and Angiosarcomas 6
- Cancer Diagnosis and Treatment 3
- CAR-T cell therapy research 2
- Co-authors
- Arthur P. Staddon (8 shared papers)Kristy Weber (3 shared papers)Abigail T. Berman (2 shared papers)Eli Glatstein (2 shared papers)Stephen M. Hahn (2 shared papers)S. Nagda (2 shared papers)Warren Chow (2 shared papers)William P. Levin (2 shared papers)
- Journals
- Journal of Clinical Oncology (9 papers)Head & Neck (3 papers)Cancer (2 papers)Journal of Surgical Oncology (2 papers)Sarcoma (1 paper)
- Partner nations
- United StatesPolandUnited Kingdom
In The Last Decade
Lee Hartner
25 papers receiving 406 citations
Peers
Comparison fields: 5 of 69
- Toxicology 24
- Pulmonary and Respiratory Medicine 217
- Rheumatology 77
- Oncology 135
- Otorhinolaryngology 21
Countries citing papers authored by Lee Hartner
This map shows the geographic impact of Lee Hartner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee Hartner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee Hartner more than expected).
Fields of papers citing papers by Lee Hartner
This network shows the impact of papers produced by Lee Hartner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee Hartner. The network helps show where Lee Hartner may publish in the future.
Co-authors
The 25 scholars most cited alongside Lee Hartner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 98 | |
| 2 | 2016 | 57 | |
| 3 | 2019 | 49 | |
| 4 | 2014 | 39 | |
| 5 | 2010 | 37 | |
| 6 | 2020 | 30 | |
| 7 | 2007 | 21 | |
| 8 | 2017 | 13 | |
| 9 | 2021 | 11 | |
| 10 | 2018 | 10 | |
| 11 | 2023 | 8 | |
| 12 | 2024 | 6 | |
| 13 | 2014 | 6 | |
| 14 | 2021 | 5 | |
| 15 | 2014 | 5 | |
| 16 | 2012 | 4 | |
| 17 | 2022 | 3 | |
| 18 | 2019 | 3 | |
| 19 | 2009 | 2 | |
| 20 | 2024 | 1 |
About Lee Hartner
Lee Hartner is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Pathology and Forensic Medicine, Otorhinolaryngology and Rheumatology, having authored 26 papers that have together received 414 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (13 papers), Vascular Tumors and Angiosarcomas (6 papers), Head and Neck Cancer Studies (4 papers), Cancer Diagnosis and Treatment (3 papers), Bone Tumor Diagnosis and Treatments (3 papers), CAR-T cell therapy research (2 papers), Salivary Gland Tumors Diagnosis and Treatment (2 papers) and Renal cell carcinoma treatment (2 papers). The work is most often cited by research in Toxicology (24 citations), Pulmonary and Respiratory Medicine (217 citations), Rheumatology (77 citations), Oncology (135 citations) and Otorhinolaryngology (21 citations). Lee Hartner has collaborated with scholars based in United States, Poland and United Kingdom. Frequent co-authors include Arthur P. Staddon, Kristy Weber, Abigail T. Berman, Eli Glatstein, Stephen M. Hahn, S. Nagda, Warren Chow, William P. Levin, James D. Kolker and Brian C. Baumann. Their work appears in journals such as Journal of Clinical Oncology, Head & Neck, Cancer, Journal of Surgical Oncology and Sarcoma.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.